Structural Heart Market Grow At + 10.5% CAGR Up To 2025 With Key Companies Abbott Medtronic, Boston Scientific Corporation, CryoLife, LivaNova, Lepu Medical, Braile Biomedica
According to a new market research study titled ‘Structural Heart Market to 2025 - Global Analysis and Forecasts by Product, Procedure and End User, the global structural heart market was valued at US$ 6,406.3 Mn in 2017 and is estimated to reach US$ 13,850.2Mn by 2025. The report highlights the trends prevalent in the global structural heart market and the factors driving the market along with the restraints that are impacting its growth.
For In-Depth Review | Get Sample Copy@ https://www.theinsightpartners.com/sample/TIPHE100001164/?opsp
Top Key Players:
• Boston Scientific Corporation
• CryoLife, Inc
• Edward Lifesciences Corporation
• LivaNova Plc
• Lepu Medical
• Braile Biomedica
• Labcor Laboratories Ltda
• Aran Biomedical Teoranta
The product segment is divided into occluders, annuloplasty rings, heart valve balloon and others. Among the product segment the occluders holds the largest market share whereas, the heart valve balloons is the fastest growing segment. The dominancy is expected to be continued by the occluders due to the advantages offered such as it reduces 50% of the meshwork material on the left atrial side and eliminates the left atrial disc microsrew it minimizes the risk of thrombus formation and damage to the distal wall of the left atrium during the implantation procedure. Also the delivery cable mechanism varies and it allows pivoting of the devices, it also have features fir the large defects and borderline length. Moreover, the devices are fully repositionable and recapturable. The market for structural heart by the product segment is expected to reach US$ 13,850.2 million by 2025 in the forecasted period. Occluders segment has the highest market share in 2017, contributing a market share of 42.0% and is expected to retain its dominance during the forecast period from 2018 to 2025 to account for a market share of 42.5% of the overall revenue generated in 2025.
Acquisitions and expansions were observed as the most adopted strategy in global structural heart industry. Few of the acquisitions and expansions made by the players in the market are listed below:
2018: In July, 2018, Boston Scientific Corporation announced signing of agreement to acquire Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel Cerebral Embolic Protection System.
2017: In November, 2017, Edwards Lifesciences Corporation, announced it expansion, the expansion was done in the Costa Rica a new manufacturing plant was started.
Want To Know More | Inquiry Here @ https://www.theinsightpartners.com/inquiry/TIPHE100001164/?opsp
Innovative Structural Heart Services:-
The rise in technological advancement has led to various innovations for the products and treatment services that enables the surgeon, physicians and other healthcare providers to provide best health to their patients. The innovations are not only limited to the healthcare facilities nevertheless they are extended to the programs that are being designed for the patients to get benefit out of the treatment facilities. Food and Drug Administration (FDA) has approved various therapies that are limited to the selected groups of the patients. There some personal healthcare provider who analyze the heart condition and available treatment of choices. For instance, Premier Health is among those providers who provides innovative structural heart services which include alcohol septal ablation which treats hypertrophic cardiomyopathy with the use of catheter-based technology, balloon valvuloplasty which uses a transcatheter approach for widening up a stiff and narrow heart valves, atrial septal defect transcatheter repair which closes an opening between the heart’s left and right atrium without surgery and such more services are being provided by the service providers.
Rise in the Number of Cardiovascular Procedure and Corresponding Training Programs:-
The cardiac arrest or the other heart related diseases are wide spreading incidence and are impacting severely on the public health and wellbeing. The cardiovascular disease are the second leading cause of death across the world. For instance, according to World Health Organization (WHO) approximately 17.7 million people died in 2015 due to the cardiovascular diseases, the number contributes to the 31% of the global deaths. The among these deaths it was estimated that near about 7.4 million deaths were due to coronary heart diseases and near about 6.7 million deaths were due to the heart stroke. Among the 17 million deaths the premature deaths were contributed due to non-communicable diseases in 2015, this number relates approximately to 82% were in low and middle-income countries, and approximately 37% were due to CVDs. Therefore, various strategies and initiations are being taken to control the cardiovascular diseases.
The global structural heart market by product was led by occluders segment. In 2017, the occluders segment held a largest market share of 42.0% of the structural heart market, by product. The segment is also expected to dominate the market during the year 2025, due to benefits such as, 50% of reduction in the meshwork material on the left atrial side and eliminates the left atrial disc microsrew, minimizes the risk of thrombus formation and damage to the distal wall of the left atrium during the implantation procedure
The structural heart market by procedure was segmented into surgical aortic valve replacement, transcatheter aortic valve replacement, mitral repair and left atrial appendage closure. The surgical aortic valve replacement segment held the largest share of the market, by procedure. The segment is also likely to dominate during the forecast period, as it helps in restoring the normal blood flow, prolong life and help to preserve the function of heart muscles.
End User Insights:-
The structural heart market by end user was segmented into hospital, ambulatory surgical centers and cardiac centers. The hospitals segment held the largest share of the market, by end user. The segment held a market share of around 49.9% during the year 2017 and is anticipated to dominate by 2025, among the end users.
• Annuloplasty Rings
• Heart Valve Balloons
• Surgical Aortic Valve Replacement
• Transcatheter Aortic Valve Replacement
• Mitral Repair
• Left Atrial Appendage Closure
By End User
• Ambulatory Surgical Centers
• Cardiac Centers
• North America
• Asia Pacific (APAC)
• Middle East & Africa (MEA)
• South America (SAM)
Get Customization On Discount@ https://www.theinsightpartners.com/discount/TIPHE100001164/?opsp
The Insight partners,
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Structural Heart Market Grow At + 10.5% CAGR Up To 2025 With Key Companies Abbott Medtronic, Boston Scientific Corporation, CryoLife, LivaNova, Lepu Medical, Braile Biomedica here
News-ID: 1777992 • Views: 132
More Releases from The Insight partners
Microbial Identification Panel Market Upcoming Opportunities with $3,873.1 Milli …
Advancement in technologies is rising in rapidly. The rising trend is making the clinical and medical diagnostics much easier. The technological advancement has reduced the time of microbial identification and analyzing procedures. It has also helped in getting outcomes more accurately and efficiently. The next-generation sequencing method has allowed understanding the genetic make-up of micro-organism for various industrial application. Microbial Identification Panel Market to 2027 - Global Analysis and Forecasts by
Foot & Ankle Devices Market to Grow with $4,084.97 Million by 2027 - Key Player …
Foot injuries are significantly high in car crashes. As per a study by the National Center for Biotechnology, around 76% of total foot & ankle car injuries occur due to head-on collisions since the lower extremities are absorb the impact at first during such accidents. However, the other 21% of foot injuries are due to roll-overs and side impacts. Foot and ankle devices such as splints, rehabilitation braces and supports,
Global Barium Market Product, End User, Marketing Channels & Forecast upto 2027
Latest Report Titled on “Barium Market to 2027 - Global Analysis and Forecasts by Derivative (Barium Sulfate, Barium Chloride, Barium Nitrate, Barium Titanate, Barium Oxide, Barium Carbonate, Others); Application (Construction, Metal Alloys, Paints & Colorants, Plastics & Rubbers, Mining, Electronics, Others)” Global Barium Market Research Report analyses the industry status, size, share, trends, growth opportunity, compsetition landscape and forecast to 2027. This report also provides data on patterns, improvements, target business
Triclosan Market Outlook 2019-2027 - Trends, Demand, Production, Sales, Supply, …
The report on Triclosan Market 2019 is one of the fastest developing element in Global Market. The Triclosan Market has observed continuous development in the past decade and is predictable to reach new levels of evolution during the estimate period 2019 to 2027. The report estimates the key elements at play in the market. To offer a clear summary of the market to user and helps to implement their Industry
More Releases for Heart
Heart Congress 2019
Coalesce Research Group proudly announces the “International Conference on Heart & Clinical Cardiology Research” at Osaka, Japan during November 14-15, 2019. This Conference will be perfect platform for scientists, professors, healthcare professionals and cardiologists. Heart Congress 2019 is designed to provide diverse and recent research education on cardiovascular disease that keeps medical professionals along with issues heartrending on diagnosis, treatment of Cardiac disorders and prevention. In recent years, cardiac and
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an
Prosthetic Heart Valve Market
Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where
Global Heart Implants Market
The Heart Implants Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. In a growing cardiac implants market where profits and growth prospects run together, many companies are vying to plunge into this untapped market. Heart implants are end-stage operations, where a failing